---
title: "Garmin EMEA Managing Director Sean Biddlecombe sells 986 shares for $288,780.23"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294561145.md"
description: "Garmin EMEA Managing Director Sean Biddlecombe sold 986 shares on July 31, 2026, at $292.88 per share, totaling approximately $288,780. His remaining holdings decreased to 6,021 shares."
datetime: "2026-07-31T22:30:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294561145.md)
  - [en](https://longbridge.com/en/news/294561145.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294561145.md)
---

# Garmin EMEA Managing Director Sean Biddlecombe sells 986 shares for $288,780.23

-   Garmin: Sean Biddlecombe, Managing Director, EMEA, sold 986 registered shares on July 31, 2026. \* Sale price USD 292.88 per share; holdings fell to 6,021 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Garmin Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-329031), on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [GRMN.US](https://longbridge.com/en/quote/GRMN.US.md)

## Related News & Research

- [GRMN: Record Q2 results, margin expansion, and raised guidance highlight strong business momentum](https://longbridge.com/en/news/294201097.md)
- [08:03 ETNatural Cycles Receives Sixth FDA Clearance for Next-Generation Fertility Algorithm](https://longbridge.com/en/news/293929269.md)
- [Volaris director Ricardo Maldonado Yanez files initial beneficial ownership statement](https://longbridge.com/en/news/294435358.md)
- [CytomX Therapeutics director Charles S. Fuchs files initial beneficial ownership statement](https://longbridge.com/en/news/294418612.md)
- [Tenet Healthcare COO Lisa Y. Foo reports sale of USD 2.58 million in common shares](https://longbridge.com/en/news/294564043.md)